Eczema breakthrough? DNA in blood could predict Flare-Ups
NCT ID NCT07573735
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether tiny DNA fragments released from damaged skin cells into the blood can help measure eczema severity. Researchers will compare blood and skin samples from 80 adults with eczema and healthy volunteers. The goal is to understand how these DNA fragments trigger immune cells, which could lead to better monitoring and new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS ECZEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongda Hospital, Southeast University
RECRUITINGNanjing, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can ozonated oil soothe eczema in kids?
- Can a new drug safely control eczema over the long haul?
- Microscopic skin scans may reveal how a new eczema drug reshapes the skin
- Worldwide eczema study aims to uncover disparities in care
- Can an amino acid supplement calm childhood eczema?
- New skin scanner could reveal hidden changes in eczema treatment